Skip to main content
. 2017 Jul 1;26(7):735–744. doi: 10.1089/jwh.2015.5639

Table 1.

Descriptive Characteristics of Older Women with Early-Stage Breast Cancer SEER -Medicare, 2003–2009

  N %
All 45924 100.0
Treatment
 BCS+RT 25038 54.5
 Mastectomy 10755 23.4
 BCS only 10131 22.1
Year of diagnosis
 2003 6620 14.4
 2004 6523 14.2
 2005 6416 14.0
 2006 6493 14.1
 2007 6563 14.3
 2008 6628 14.4
 2009 6681 14.6
Age & health
 Age at diagnosis
  66–69 10319 22.5
  70–74 11728 25.5
  75–79 10718 23.3
  80–84 7974 17.4
  85–89 3900 8.5
  ≥ 90 1285 2.8
 Comorbidity score
  0 26024 56.7
  1 12422 27.1
  ≥ 2 7478 16.3
 PCP visits
  Low 24805 54.0
  High 21119 46.0
Clinical prognostic factors
 Stage at diagnosis
  I 28884 62.9
  II 17040 37.1
 ER status
  Positive 36321 79.1
  Negative 6298 13.7
  Borderline/unknown 3305 7.2
 PR status
  Positive 30470 66.4
  Negative 11754 25.6
  Borderline/unknown 3700 8.1
 Tumor size
  0–1 cm 14837 32.3
  <2 cm 18001 39.2
  2–5 cm 12371 26.9
  >5 cm 715 1.6
 Tumor grade
  Well differentiated 12096 26.3
  Moderately differentiated 20024 43.6
  Poorly differentiated 10826 23.6
  Undifferentiated/unknown 2978 6.5
Oncology care resources
 Mammography screening centers
  Low 23761 51.7
  High 22163 48.3
 Oncology treatment centers
  Low 25733 56.0
  High 20191 44.0
 Type of surgeon seen
  General only 8536 18.6
  Oncology only 2640 5.8
  Both 34748 75.7
Socio-demographic characteristics
 Race
  White 41034 89.4
  Other 4890 10.7
 Education
  <15% college degree 13543 29.5
  ≥15% college degree 32381 70.5
 Annual income
  ≤$35,000 10839 23.6
  >$35,000 35085 76.4
 Metro status
  Nonmetro 7673 16.7
  Metro 38251 83.3

BCS, breast-conserving surgery; RT, radiation therapy; PCP, primary care physician; ER, estrogen receptor; PR, progesterone receptor; SEER, Surveillance, Epidemiology, and End Results.